Organogenesis Holdings Inc.
ORGO
$4.88
$0.214.50%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 126.66M | 115.18M | 130.23M | 109.98M | 99.65M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 126.66M | 115.18M | 130.23M | 109.98M | 99.65M |
| Cost of Revenue | 31.05M | 26.80M | 29.20M | 28.70M | 27.77M |
| Gross Profit | 95.61M | 88.38M | 101.04M | 81.28M | 71.88M |
| SG&A Expenses | 73.86M | 71.80M | 76.54M | 72.32M | 59.46M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 116.44M | 108.94M | 121.33M | 113.83M | 99.00M |
| Operating Income | 10.22M | 6.24M | 8.91M | -3.85M | 649.00K |
| Income Before Tax | 10.25M | 5.82M | -14.54M | -4.34M | -1.80M |
| Income Tax Expenses | 2.58M | -6.51M | 2.50M | -2.24M | -1.23M |
| Earnings from Continuing Operations | 7.67M | 12.33M | -17.04M | -2.10M | -568.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 7.67M | 12.33M | -17.04M | -2.10M | -568.00K |
| EBIT | 10.22M | 6.24M | 8.91M | -3.85M | 649.00K |
| EBITDA | 14.67M | 10.65M | 13.11M | 121.00K | 4.86M |
| EPS Basic | 0.05 | 0.09 | -0.13 | -0.02 | 0.00 |
| Normalized Basic EPS | 0.05 | 0.03 | 0.04 | -0.02 | 0.00 |
| EPS Diluted | 0.04 | 0.09 | -0.13 | -0.02 | 0.00 |
| Normalized Diluted EPS | 0.05 | 0.03 | 0.04 | -0.02 | 0.00 |
| Average Basic Shares Outstanding | 129.68M | 132.58M | 132.57M | 131.86M | 130.92M |
| Average Diluted Shares Outstanding | 132.16M | 133.93M | 132.57M | 131.86M | 131.86M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |